FDA
-
-
-
-
-
-
-
Fusion Pharmaceuticals (FUSN) Announces Clinical Program and Manufacturing Updates
-
-
-
-
-
-
-
Fusion Pharmaceuticals (FUSN) Announces 17.6M Share Offering at $3.40/sh, Acquires Phase 2 Program for 225Ac-PSMA I&T
-
-
-
-
-
-
-
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Chau Khuong Joins Catalio Capital Management as General Partner
-
-
-
-
322,240 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

